Artificial Organs: Global Markets

Artificial Organs: Global Markets

Report Scope:

This report is a comprehensive study of the global artificial organs market. It describes the artificial organs market, segmented by product type and region. Based on product type, the market is segmented into artificial hearts, artificial kidneys, artificial lungs, artificial pancreases, and cochlear implants. The market is segmented by region into North America, Latin America, Europe, Asia-Pacific, and the Rest of the World (RoW).

This report examines the factors driving growth in the artificial organ market, and it reviews major players, established companies, and new entrants.

This report, however, does not cover artificial limbs, artificial eyes, artificial intestines, artificial skin, or artificial blood vessels.

Report Includes:

28 data tables and 14 additional tables

An overview of the global artificial organs market

Analyses of global market trends, with data from 2020 to 2022, estimates for 2023 and projections of compound annual growth rates (CAGRs) through 2028

Discussion about the benefits of using artificial organs over traditional organs in transplantation surgeries, and increase in development of new types of artificial organs as driving factors to the market

Identification of challenges and discussion on how to overcome from those to reach its commercialization potential

Insights into R&D investments, government growth-promoting policies, rules, and regulations

Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the market and a relevant patent analysis

Detailed company profiles of major players in the market, including Abbott, Getinge AB, LivaNova, Nipro Corp. and Sonova

Companies Mentioned

ABBOTT
ABIOMED
B. Braun Se
BAXTER INTERNATIONAL INC.
COCHLEAR LTD.
F. HOFFMANN-LA ROCHE LTD.
FRESENIUS MEDICAL CARE AG & CO. KGAA
GETINGE AB
INSULET CORP.
LIVANOVA PLC
MED-EL MEDICAL ELECTRONICS
MEDTRONIC
NIPRO CORP.
SONOVA
TANDEM DIABETES CARE, INC.
TERUMO CORP.
YPSOMED AG